Acciones Axis-Shield Ltd

Acciones

Diferido London S.E. Otros sitios de cotización			Varia. Cinco días.	Varia. 1 de enero.
- ^GBX	-.--%		-.--%	-.--%

Duración

Período

Estilo

Axis Shield : The Effect of Food Intake on the Pharmacokinetics of Vadadustat Following Single Dose Administration	29/07/20
Axis Shield : Randomized, Double-Blinded, Active-Controlled (Darbepoetin Alfa), Phase 3 Study of Vadadustat in Chronic Kidney Disease Patients With Anemia on Hemodialysis in Japan	29/07/20
Axis Shield : Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia	29/07/20
Axis Shield : Targeted Literature Review of Patient-reported Burden of Anemia in Chronic Kidney Disease	29/07/20
Efficacy and Safety of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Being Evaluated for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Japanese Subjects: Results from Phase 2 Studies (encore)	29/07/20

Axis-Shield Ltd es una empresa con sede en el Reino Unido. La empresa desarrolla, fabrica y comercializa productos de diagnóstico in vitro.

Sector

	Varia. 1 de ene.	Capi.
AXIS-SHIELD LTD	-.--%	0
BIOMÉRIEUX	-9,74 %	11,48 mil M
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-9,80 %	7638,77 M
LANTHEUS HOLDINGS, INC.	+27,84 %	5493,72 M
AUTOBIO DIAGNOSTICS CO., LTD.	-15,47 %	3855,58 M
ANDON HEALTH CO., LTD.	+8,47 %	2607,27 M
10X GENOMICS, INC.	-63,81 %	2424,1 M
VITROLIFE AB	-9,24 %	2270,9 M
MYRIAD GENETICS, INC.	+21,21 %	2099,79 M
GUANGZHOU WONDFO BIOTECH CO.,LTD	-9,38 %	1764,28 M